Enlivex Ltd (ENLV)

• Market cap: $35.2M
• 1 day: 7.18%
• 5 days: -50.47%
• 1 month: -74.67%
• 3 months: -83.01%
• 6 months: -86.6%
• Year to date: -81.54%
• 1 year: -90.65%
• 5 years: -98.36%
• 10 years: -99.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Employees: 34